CELZ
Creative Medical Technology Holdings Inc
NASDAQ: CELZ · HEALTHCARE · BIOTECHNOLOGY
$2.25
+1.35% today
Updated 2026-04-30
Market cap
$8.50M
P/E ratio
—
P/S ratio
1,417.06x
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$2 – $6
Volume
0.1M
Creative Medical Technology Holdings Inc (CELZ) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-64,859.00%
ROE
-86.50%
ROA
-53.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $1372.00 | — | — | — |
| 2007 | — | $-9544.00 | — | — | — |
| 2008 | — | $-52636.00 | — | — | — |
| 2009 | — | $-31610.00 | — | — | — |
| 2010 | — | $-17256.00 | — | — | — |
| 2011 | — | $-24055.00 | — | — | — |
| 2012 | — | $-25585.00 | — | — | — |
| 2013 | — | $-27282.00 | — | — | — |
| 2014 | $0.00 | $-28012.00 | — | — | — |
| 2015 | $0.00 | $-30761.00 | — | — | — |
| 2016 | $0.00 | $-766072.00 | — | — | — |
| 2017 | $4800.00 | $-2.66M | -66.67% | -24,537.63% | -55,398.08% |
| 2018 | $124400.00 | $-13.66M | 43.43% | -895.68% | -10,977.21% |
| 2019 | $165500.00 | $-8.48M | 72.51% | -682.88% | -5,126.09% |
| 2020 | $164500.00 | $-36.33M | 69.24% | -677.71% | -22,082.21% |
| 2021 | $87754.00 | $19.21M | 45.36% | -3,562.17% | 21,892.75% |
| 2022 | $88600.00 | $-10.14M | 67.84% | -11,562.50% | -11,449.26% |
| 2023 | $9000.00 | $-5.29M | 60.00% | -62,445.91% | -58,739.71% |
| 2024 | $11000.00 | $-5.49M | 60.00% | -52,216.92% | -49,940.74% |
| 2025 | $6000.00 | $-6.00M | -1,992.02% | -102,380.23% | -99,916.80% |